Advisor Partners’s Chemed CHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$340K Buy
725
+80
+12% +$39K 0.02% 598
2022
Q1
$327K Buy
645
+31
+5% +$14.9K 0.02% 644
2021
Q4
$325K Sell
614
-63
-9% -$30.2K 0.02% 646
2021
Q3
$315K Sell
677
-34
-5% -$16K 0.02% 631
2021
Q2
$337K Sell
711
-32
-4% -$15.4K 0.02% 620
2021
Q1
$342K Buy
743
+63
+9% +$30.9K 0.02% 591
2020
Q4
$362K Buy
680
+14
+2% +$6.88K 0.03% 539
2020
Q3
$320K Buy
666
+16
+2% +$7.85K 0.03% 508
2020
Q2
$293K Buy
650
+38
+6% +$17K 0.03% 522
2020
Q1
$265K Buy
612
+40
+7% +$17.9K 0.03% 473
2019
Q4
$268K Sell
572
-5
-0.9% -$2.1K 0.03% 522
2019
Q3
$241K Buy
+577
New +$236K 0.03% 555

Other funds holding CHE

Advisor Partners's CHE Position: Q2 2022 in Review

Advisor Partners increased its Chemed (CHE) stake by 12% in Q2 2022, buying an estimated $39K and bringing the position to 725 shares worth $340K. The position accounts for 0.02% of the portfolio, ranked #598.

Advisor Partners first reported a position in CHE in Q3 2019 and has held it in 12 quarters since. The position peaked at $362K in Q4 2020. 429 funds tracked by Wall St. Rank hold CHE as of Q2 2022.

  • Advisor Partners held 725 shares of Chemed worth $340K as of Q2 2022.
  • Advisor Partners bought 80 Chemed shares in Q2 2022, an estimated $39K.
  • Chemed made up 0.02% of Advisor Partners's portfolio in Q2 2022, its #598 holding.
  • Advisor Partners first reported a position in Chemed in Q3 2019 and has held it in 12 quarters since.
  • Advisor Partners's Chemed position peaked at $362K in Q4 2020.
  • 429 funds tracked by Wall St. Rank held Chemed as of Q2 2022.

Based on Advisor Partners's 13F filing for Q2 2022, filed 11 Aug 2022.